home / stock / ganx / ganx quote
Last: | $1.16 |
---|---|
Change Percent: | 0.0% |
Open: | $1.19 |
Close: | $1.16 |
High: | $1.2 |
Low: | $1.13 |
Volume: | 157,635 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.16 | $1.19 | $1.16 | $1.2 | $1.13 | 157,635 | 07-04-2024 |
$1.16 | $1.19 | $1.16 | $1.2 | $1.13 | 157,635 | 07-03-2024 |
$1.195 | $1.2 | $1.195 | $1.2 | $1.12 | 267,227 | 07-02-2024 |
$1.12 | $1.26 | $1.12 | $1.265 | $1.11 | 625,155 | 07-01-2024 |
$1.28 | $1.2 | $1.28 | $1.32 | $1.2 | 551,544 | 06-28-2024 |
$1.25 | $1.29 | $1.25 | $1.3 | $1.23 | 325,115 | 06-27-2024 |
$1.27 | $1.27 | $1.27 | $1.3 | $1.2519 | 239,508 | 06-26-2024 |
$1.3 | $1.29 | $1.3 | $1.34 | $1.26 | 587,078 | 06-25-2024 |
$1.29 | $1.3 | $1.29 | $1.32 | $1.24 | 270,347 | 06-24-2024 |
$1.29 | $1.31 | $1.29 | $1.3191 | $1.23 | 380,744 | 06-21-2024 |
$1.3 | $1.28 | $1.3 | $1.3 | $1.2 | 568,826 | 06-20-2024 |
$1.28 | $1.31 | $1.28 | $1.36 | $1.26 | 455,473 | 06-19-2024 |
$1.28 | $1.31 | $1.28 | $1.36 | $1.26 | 455,473 | 06-18-2024 |
$1.32 | $1.28 | $1.32 | $1.38 | $1.27 | 1,024,400 | 06-17-2024 |
$1.24 | $1.46 | $1.24 | $1.46 | $1.23 | 3,085,061 | 06-14-2024 |
$1.89 | $2.14 | $1.89 | $2.176 | $1.8 | 541,780 | 06-13-2024 |
$2.11 | $2.43 | $2.11 | $2.43 | $2.07 | 339,103 | 06-12-2024 |
$2.43 | $2.08 | $2.43 | $2.44 | $2.07 | 137,853 | 06-11-2024 |
$2.09 | $2.2 | $2.09 | $2.57 | $2.03 | 213,889 | 06-10-2024 |
$2.2 | $2.28 | $2.2 | $2.4679 | $2.16 | 102,867 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Gain Therapeutics Inc. Company Name:
GANX Stock Symbol:
NASDAQ Market:
Gain Therapeutics Inc. Website:
BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announc...
Mr. Mack is the Company’s Current CFO Khalid Islam, PhD, Founder and Chairman of the Board, to serve as Executive Chairman BETHESDA, Md., June 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clini...
BETHESDA, Md., June 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announc...